About XW Labs

XW Laboratories is an Asia-Pacific biopharmaceutical company dedicated to discovering and developing transformational medicines that will markedly improve the quality of life in patients suffering from neurological disorders.

Founded in 2014, XW Laboratories has developed 3 unique drug R&D platforms that not only allow us to improve upon existing medication through approaches such as prodrug and functional group switch, but also be at the forefront of medicinal technology in immunoneurology through the application of our mitochondria-targeting platform.

With our drug R&D platforms and team of expert research scientists, we hope to bring a combination of improvements of existing therapeutics and novel drugs to patients worldwide.